(Q40548123)

21 September 2017

1 reference

title

Attenuated-dose idarubicin in acute myeloid leukaemia of the elderly: pharmacokinetic study and clinical results (English)

1 reference

21 September 2017

1 reference

1 reference

Leoni F

1

1 reference

21 September 2017

Ciolli S

2

1 reference

21 September 2017

Giuliani G

3

1 reference

21 September 2017

Pascarella A

4

1 reference

21 September 2017

Caporale R

5

1 reference

21 September 2017

Salti F

6

1 reference

21 September 2017

Cervi L

7

1 reference

21 September 2017

Rossi Ferrini P

8

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 May 1995

1 reference

British Journal of Haematology

21 September 2017

published in

1 reference

21 September 2017

volume

90

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

169-174

1 reference

Acute myeloblastic leukaemia in the elderly

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03396.X

A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03396.X

The disposition of cytotoxic drugs in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03396.X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB03396.X

10.1111/J.1365-2141.1995.TB03396.X

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference